Global Retirement Partners’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125K Buy
+1,668
New +$107K ﹤0.01% 1912
2025
Q4
$270K Buy
+3,370
New +$226K ﹤0.01% 1296
2024
Q1
Sell
-11
Closed -$910 3430
2023
Q4
$910 Hold
11
﹤0.01% 2924
2023
Q3
$952 Hold
11
﹤0.01% 2786
2023
Q2
$937 Hold
11
﹤0.01% 2802
2023
Q1
$900 Buy
+11
New +$890 ﹤0.01% 2766

Other funds holding HAE

Global Retirement Partners's HAE Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Haemonetics (HAE) in Q2 2026: 1,668 shares worth $125K. The stake represents ﹤0.01% of the portfolio and ranks #1912 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in HAE as recently as Q4 2025.

Global Retirement Partners first reported a position in HAE in Q1 2023 and has held it in 6 quarters since. The position peaked at $270K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Global Retirement Partners held 1,668 shares of Haemonetics worth $125K as of Q2 2026.
  • Haemonetics was a new Global Retirement Partners position in Q2 2026.
  • Haemonetics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1912 holding.
  • Global Retirement Partners first reported a position in Haemonetics in Q1 2023 and has held it in 6 quarters since.
  • Global Retirement Partners's Haemonetics position peaked at $270K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.